Perioperative management of a patient with hereditary angioedema during off-pump coronary artery bypass graft surgery. 2010

Vladislav Shick, and Vajubhai Sanchala, and Kathryn E McGoldrick, and John J Tartaglia, and John Nelson, and Arlen J Fleisher
Department of Anesthesiology, New York Medical College and Westchester Medical Center, Valhalla, NY 10595, USA. shickvl@yahoo.com

The case of a patient with hereditary angioedema (HAE), a rare, life-threatening disorder caused by reduced activity of the C1 esterase inhibitor, and requiring off-pump coronary artery bypass graft (OP-CABG) surgery, is presented. Perioperative management of patients with HAE who undergo complex cardiac surgical procedures are discussed, including an OP-CABG surgical approach to decrease complement activation, fresh-frozen plasma administration to increase C1 esterase inhibitor activity, and administration of reduced doses of heparin and protamine to minimize heparin-protamine complex formation.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010949 Plasma The residual portion of BLOOD that is left after removal of BLOOD CELLS by CENTRIFUGATION without prior BLOOD COAGULATION. Blood Plasma,Fresh Frozen Plasma,Blood Plasmas,Fresh Frozen Plasmas,Frozen Plasma, Fresh,Frozen Plasmas, Fresh,Plasma, Blood,Plasma, Fresh Frozen,Plasmas,Plasmas, Blood,Plasmas, Fresh Frozen
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000925 Anticoagulants Agents that prevent BLOOD CLOTTING. Anticoagulant Agent,Anticoagulant Drug,Anticoagulant,Anticoagulant Agents,Anticoagulant Drugs,Anticoagulation Agents,Indirect Thrombin Inhibitors,Agent, Anticoagulant,Agents, Anticoagulant,Agents, Anticoagulation,Drug, Anticoagulant,Drugs, Anticoagulant,Inhibitors, Indirect Thrombin,Thrombin Inhibitors, Indirect
D047549 Coronary Artery Bypass, Off-Pump Coronary artery bypass surgery on a beating HEART without a CARDIOPULMONARY BYPASS (diverting the flow of blood from the heart and lungs through an oxygenator). Beating Heart Coronary Artery Bypass,Off-Pump Coronary Artery Bypass,Coronary Artery Bypass, Beating Heart,Coronary Artery Bypass, Off Pump,Off Pump Coronary Artery Bypass
D050718 Complement C1 Inhibitor Protein An endogenous 105-kDa plasma glycoprotein produced primarily by the LIVER and MONOCYTES. It inhibits a broad spectrum of proteases, including the COMPLEMENT C1R and the COMPLEMENT C1S proteases of the CLASSICAL COMPLEMENT PATHWAY, and the MANNOSE-BINDING PROTEIN-ASSOCIATED SERINE PROTEASES. C1-INH-deficient individuals suffer from HEREDITARY ANGIOEDEMA TYPES I AND II. C1 Esterase Inhibitor,C1-INH Protein,C1-Inhibitor Protein,Complement C1-Inhibitor Protein,Plasma Protease C1 Inhibitor,SERPING1,Serpin Family G Member 1,Serpin G1,C1 INH Protein,C1 Inhibitor Protein,Esterase Inhibitor, C1
D054179 Angioedemas, Hereditary Inherited disorders that are characterized by subcutaneous and submucosal EDEMA in the upper RESPIRATORY TRACT and GASTROINTESTINAL TRACT. Angioedema, Hereditary,Angioneurotic Edema, Hereditary,C1 Esterase Inhibitor Deficiency,C1 Inhibitor Deficiency,Hereditary Angioedema,Hereditary Angioedemas,Hereditary Angioneurotic Edema,Angioneurotic Edemas, Hereditary,Edema, Hereditary Angioneurotic,Edemas, Hereditary Angioneurotic,Hereditary Angioneurotic Edemas
D019990 Perioperative Care Interventions to provide care prior to, during, and immediately after surgery. Care, Perioperative

Related Publications

Vladislav Shick, and Vajubhai Sanchala, and Kathryn E McGoldrick, and John J Tartaglia, and John Nelson, and Arlen J Fleisher
August 2002, Journal of cardiothoracic and vascular anesthesia,
Vladislav Shick, and Vajubhai Sanchala, and Kathryn E McGoldrick, and John J Tartaglia, and John Nelson, and Arlen J Fleisher
March 2008, The Annals of thoracic surgery,
Vladislav Shick, and Vajubhai Sanchala, and Kathryn E McGoldrick, and John J Tartaglia, and John Nelson, and Arlen J Fleisher
October 2000, Journal of cardiothoracic and vascular anesthesia,
Vladislav Shick, and Vajubhai Sanchala, and Kathryn E McGoldrick, and John J Tartaglia, and John Nelson, and Arlen J Fleisher
March 2014, Global journal of health science,
Vladislav Shick, and Vajubhai Sanchala, and Kathryn E McGoldrick, and John J Tartaglia, and John Nelson, and Arlen J Fleisher
April 2000, Journal of cardiothoracic and vascular anesthesia,
Vladislav Shick, and Vajubhai Sanchala, and Kathryn E McGoldrick, and John J Tartaglia, and John Nelson, and Arlen J Fleisher
December 2000, Journal of cardiothoracic and vascular anesthesia,
Vladislav Shick, and Vajubhai Sanchala, and Kathryn E McGoldrick, and John J Tartaglia, and John Nelson, and Arlen J Fleisher
January 2018, Annals of cardiac anaesthesia,
Vladislav Shick, and Vajubhai Sanchala, and Kathryn E McGoldrick, and John J Tartaglia, and John Nelson, and Arlen J Fleisher
October 2005, Journal of cardiothoracic and vascular anesthesia,
Vladislav Shick, and Vajubhai Sanchala, and Kathryn E McGoldrick, and John J Tartaglia, and John Nelson, and Arlen J Fleisher
January 2014, Annals of cardiac anaesthesia,
Vladislav Shick, and Vajubhai Sanchala, and Kathryn E McGoldrick, and John J Tartaglia, and John Nelson, and Arlen J Fleisher
January 2022, Annals of cardiac anaesthesia,
Copied contents to your clipboard!